Europe Sarcopenia Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Sarcopenia Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Sarcopenia Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Sarcopenia Treatment Market Regional Analysis

6.2 Europe Sarcopenia Treatment Market Revenue 2020-2030 (US$ Million)

6.3 Europe Sarcopenia Treatment Market Forecast Analysis

7. Europe Sarcopenia Treatment Market Analysis – by Treatment Type

7.1 Vitamin D and Calcium Supplement

7.1.1 Overview
7.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Protein Supplement

7.2.1 Overview
7.2.2 Protein Supplement: Europe Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Vitamin B12 Supplement

7.3.1 Overview
7.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Sarcopenia Treatment Market Analysis – by Distribution Channel

8.1 Pharmacies

8.1.1 Overview
8.1.2 Pharmacies: Europe Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Retail Channels

8.2.1 Overview
8.2.2 Retail Channels: Europe Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Online Channels

8.3.1 Overview
8.3.2 Online Channels: Europe Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Sarcopenia Treatment Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Sarcopenia Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
9.2.1.1 Europe Sarcopenia Treatment Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.1.1 UK: Europe Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.1.2 UK: Europe Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.2 Germany: Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.2.1 Germany: Europe Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.2.2 Germany: Europe Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.3 France: Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.3.1 France: Europe Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.3.2 France: Europe Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.4 Russia: Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.4.1 Russia: Europe Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.4.2 Russia: Europe Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.5 Italy: Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.5.1 Italy: Europe Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.5.2 Italy: Europe Sarcopenia Treatment Market Breakdown, by Distribution Channel

9.2.1.6 Rest of Europe: Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Sarcopenia Treatment Market Breakdown, by Treatment Type
9.2.1.6.2 Rest of Europe: Europe Sarcopenia Treatment Market Breakdown, by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Amway Corp

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Bayer AG

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 GSK Plc

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Metagenics LLC

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Nestle Health Science SA

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Novartis AG

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Pfizer Inc

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Sanofi SA

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Sarcopenia Treatment Market

Analysis - by Treatment Type (Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement, and Others) and Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others)